Prof. Dr. med. Christian Brandts
hematology, oncology, cancer researchers and palliative care
hematology, oncology, cancer researchers and palliative care
Overview
Country, City
Germany, Frankfurt am Main
Health facility
University Hospital Frankfurt am Main
Medical unit
University Center for Tumour Diseases (UCT)
About the doctor
Skills & Expertise
cancer
myeloid
leukemia
myeloid leukemia
acute myeloid leukemia
chemotherapy
mutations
sorafenib
acute promyelocytic leukemia
oncology
tumor
myeloproliferative
hematology
intensive induction chemotherapy
lung
cancer research
hematology oncology
lung cancer
hematopoietic stem cells
neck
carcinoma
palliative
idarubicin
chemoradiotherapy
stem cell transplantation
malignancies
neoadjuvant
salivary
gland
bowel
nivolumab
multidrugresistant
Resume
CV (Curriculum Vitae)
Education
- 1989-1996 Human Medicine, Free University of Berlin
- 1993-1994 Human Medicine, New York University
- 1996-1999 Residency, University Hospital Charite Berlin
- 1999-2002 Postdoctoral fellowship, cancer research, University of California
- 2002-2007 Residency, University Hospital Munster
- 2006 Board certification in internal medicine
- 2007 Board certification in hematology and oncology
- 2015 Board certification in palliative care
Experience
- 2007 Assistant Physician, Department of hematology and oncology, University Hospital Frankfurt am Main of Goethe-University
- 2016 W3 Professor, Head of University Center for Tumour Diseases at University Hospital Frankfurt am Main of Goethe-University
Awards & Memberships
- Co-speaker for the German Network of Comprehensive Cancer Centers (German cancer aid)
- Board member of the German Working Group of Cancer Centers
- Co-speaker of two clinician scientists programs in Frankfurt (Mildred Scheel Career Center, Else Kroner research program) to promote the academic careers of young cancer researchers
- 2019 Board Member of the Organisation of European Cancer Institutes
Languages
English
German
Publications
P1319: TREATMENT WITH MIDOSTAURIN AND OTHER FLT3 TARGETING INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WITH FLT3 MUTATED AML WHO UNDERWENT ALLOGENEIC HCT
August, 2023
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML
August, 2023
P447: DECIPHERING THE MITOPHAGY RECEPTOR NETWORK IDENTIFIES A CRUCIAL ROLE FOR OPTINEURIN IN ACUTE MYELOID LEUKEMIA
August, 2023
Location
Theodor-Stern-Kai, 7, 60596 Frankfurt am Main, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Christian Brandts?
The primary specialization of the doctor is hematology, oncology, cancer researchers and palliative care.
What is the experience of the specialist?
Prof. Dr. med. Christian Brandts has been practicing for more than 28 years.
Prof. Dr. med. Christian Brandts
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Christian Brandts